cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Replimune Group Inc
3 own
3 watching
Current Price
$9.46
$0.64
(7.26%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
629.75M
52-Week High
52-Week High
24.81
52-Week Low
52-Week Low
4.92
Average Volume
Average Volume
2M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization629.75M
icon52-Week High24.81
icon52-Week Low4.92
iconAverage Volume2M
iconDividend Yield--
iconP/E Ratio--
What does the Replimune Group Inc do?
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immulytic platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1 that is in Phase I/II clinical trials for a range of solid tumors. It is also developing RP2, which is in Preclinical trials to express an anti-CTLA-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Preclinical trials to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.
Read More
How much money does Replimune Group Inc make?
News & Events about Replimune Group Inc.
TipRanks Financial Blog
11 months ago
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amneal Pharmaceuticals (AMRX Research Report), Replimune Group ... Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amneal Pharmaceuticals (AMRX Research Report), Replimune Group...
Stock Options Channel
11 months ago
Investors considering a purchase of Replimune Group Inc (REPL) shares, but tentative about paying the going market price of 23.25/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put...
Globe Newswire
1 year ago
NAARDEN, Netherlands and MUNICH, Germany, May 04, 2023 (GLOBE NEWSWIRE) -- Forbion, a leading European life sciences venture capital firm, announces the appointment of Silva Deelan PhD, as Forbions first Head of Impact & ESG. Silva has over 15 years of experience in ESG integration, sustainability ...
Globe Newswire
1 year ago
Forbions largest fundraising to date750 million raised in the final close of the Forbion Ventures Fund VI 600 million raised in the final close of the Forbion Growth Opportunities Fund II Brings the total of funds under management at Forbion to 3 billion NAARDEN, The Netherlands and MUNICH, Germany...
Globe Newswire
1 year ago
WOBURN, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of a novel portfolio of tumor-directed oncolytic immunotherapies, today announced that members from the Replimune management team will present and...
Frequently Asked Questions
Frequently Asked Questions
What is Replimune Group Inc share price today?
plus_minus_icon
Can Indians buy Replimune Group Inc shares?
plus_minus_icon
How can I buy Replimune Group Inc shares from India?
plus_minus_icon
Can Fractional shares of Replimune Group Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Replimune Group Inc stocks?
plus_minus_icon
What is today’s traded volume of Replimune Group Inc?
plus_minus_icon
What is today’s market capitalisation of Replimune Group Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Replimune Group Inc?
plus_minus_icon
What percentage is Replimune Group Inc down from its 52-Week High?
plus_minus_icon
What percentage is Replimune Group Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$9.46
$0.64
(7.26%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00